PYC Therapeutics (ASX:PYC) has announced it is progressing the two-part trial of its PYC-003 for Polycystic Kidney Disease. …
Latest Video
New Stories
-
Radiopharm Theranostics receives IND approval to initiate Phase 1 study
July 28, 2025 - - Australian Biotech -
Clarity successfully completes $203 million institutional placement
July 28, 2025 - - Australian Biotech -
US and EU secure new trade agreement, but 'more to come' on pharmaceuticals
July 28, 2025 - - Latest News -
Hepatitis Australia wants action as new analysis reveals many still missing cures
July 28, 2025 - - Latest News -
Leading stakeholders call for urgency on national genomics framework
July 28, 2025 - - Latest News -
Ok for North Korea to have a say on our health responses, but not the US
July 28, 2025 - - Latest News -
The Dispatched 'Week in Review' Podcast - 27 July
July 27, 2025 - - Podcast